Specify a stock or a cryptocurrency in the search bar to get a summary
Circio Holding ASA
CRNACircio Holding ASA, a biotechnology company, develops novel circular RNA and immunotherapy medicines. The company is developing TG01, a cancer vaccine targeting driver mutations, which is in three clinical trials for multiple myeloma, and pancreatic and lung cancer; and circVec circRNA vector platform, a modular genetic cassette for biogenesis of multifunctional circRNAs in human cells. The company was formerly known as Targovax ASA and changed its name to Circio Holding ASA in May 2023. The company was incorporated in 2010 and is based in Oslo, Norway. Address: St. Olavs Plass 5, Oslo, Norway, 0165
Analytics
WallStreet Target Price
54.63 NOKP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures CRNA
Dividend Analytics CRNA
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History CRNA
Stock Valuation CRNA
Financials CRNA
Results | 2019 | Dynamics |